UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
GC Pharma’s flu vaccine sales surge
GC Pharma said Thursday that the sales of Peramiflu, an influenza vaccine, ...
by Lee Han-soo
|
2018-02-01 13:59
라인
Participation in clinical trials limited to two times a year
The government said it would limit the healthy number adults can participat...
by Lee Hye-seon
|
2018-02-01 13:25
라인
Researchers identify cause for diabetic kidney disease
Researchers at Ulsan National Institute of Science and Technology (UNIST) h...
by Lee Han-soo
|
2018-02-01 11:13
라인
Castleman disease patients to see drastic cuts in treatment cost
Janssen Korea said that the Ministry of Health and Welfare granted coverage...
by Marian Chu
|
2018-02-01 10:53
라인
Young Koreans suffer ‘Bitcoin blues’ in smashed get-rich-quick dream
“One of the senior managers at my company invested 100 million won ($93,545...
by Marian Chu
|
2018-02-01 10:38
라인
CHA Medical Group gets majority stake in Australian fertility center
CHA Medical Group (CMG) said Wednesday that it has signed a stock acquisiti...
by Lee Han-soo
|
2018-01-31 17:37
라인
Bukwang wins patent for levodopa-induced dyskinesia drug candidate
Bukwang Pharmaceutical said Wednesday that it has acquired a patent for JM-...
by Lee Han-soo
|
2018-01-31 16:36
라인
Bio-fever to continue as companies apply for KOSDAQ listing
The bio-fever in Korea's stock market will continue this year as more t...
by Lee Han-soo
|
2018-01-31 15:35
라인
Overheated DHP Korea stocks face short-term trade limit
DHP Korea, a manufacturer of eye drops and other ophthalmic agents, faced a...
by Nam Doo-hyun
|
2018-01-31 15:34
라인
Opioid painkiller Tramadol banned for minors under 12
The government said it would ban the use of tramadol, a narcotic analgesic ...
by Lee Hye-seon
|
2018-01-31 15:30
라인
Korean biosimilars expand global presence
Korean biosimilar drugs have begun to expand their presence in the global m...
by So Jae-hyeon
|
2018-01-31 11:51
라인
M3DICINE unveils AI-enabled stethoscope system
M3DICINE, an Australian medical device design, and manufacturing company, a...
by Lee Han-soo
|
2018-01-31 10:54
라인
CJ Healthcare, NCPC GeneTech agree on tech transfer
CJ Healthcare said Wednesday that it has signed an agreement with NCPC Gene...
by Lee Han-soo
|
2018-01-31 10:14
라인
Foreign investors interested in Korean biosimilar, Botox makers
Korea Investment and Securities said Tuesday that foreign investors are int...
by Marian Chu
|
2018-01-30 18:13
라인
Medipost turns profitable after posting record sales
Medipost said Tuesday that it recorded 42.2 billion won ($39.3 million) in ...
by Lee Han-soo
|
2018-01-30 17:44
라인
Korean hospitals jump into developing medical AI-technology
Large Korean hospitals are taking an active approach to creating and implem...
by Marian Chu
|
2018-01-30 16:52
라인
Researchers develop AI that improves accuracy for genome editing
Researchers at Seoul National University College of Engineering and Yonsei ...
by Lee Han-soo
|
2018-01-30 16:43
라인
KUAH to build ‘minimal transfusion surgical hospital’
Korea University Anam Hospital (KUAH) said it would become the nation’s fir...
by Song Soo-youn
|
2018-01-30 15:47
라인
FedEx sees opportunities in healthcare business
Package delivery companies are essential players in the healthcare industry...
by So Jae-hyeon
|
2018-01-30 14:47
라인
Government to ban combination treatment of Stocrin and Zepatier
The Ministry of Food and Drug Safety said Monday it would prohibit combinat...
by Lee Han-soo
|
2018-01-30 14:42
-
이전
241
242
243
244
245
246
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top